Published

Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Chemistry - A European Journal
Date: 2021-08-19
Source: Crossref
DOI: 10.1002/chem.202101382
PubMed: 34062028

Authors

Lenz Claudius Dörner Sebastian Sherwood Alexander Hoffmeister Dirk

Watch author

Derived topics and classifications

psilocybin psilocin General Other

Citation graph

32 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

10.1016/j.euroneuro.2013.12.006 10.1021/acsmedchemlett.0c00048 10.1038/s41429-020-0311-8 10.1002/cplu.202000581 10.1002/chem.201802758 10.1002/anie.201910175 10.1002/ange.201910175 10.1016/0006-2952(60)90036-8 10.1111/j.1476-5381.1960.tb00290.x 10.1038/2151292a0 10.1002/jlac.1991199101187 10.1515/znb-1993-1016

Indexed papers citing this DOI

Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs2026-03-18 Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms2025-11-25 Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry2024-02-01 Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines2022-07-05 Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization2021-08-19

Related papers

Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).ClinicalTrials.gov · 2025-04-11 Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19 Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyClinicalTrials.gov · 2024-04-25